- Home
- OPK vs OCUL Comparison
OPK vs OCUL Comparison
Compare OPK & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- OCUL
- Stock Information
- Founded
- OPK 2007
- OCUL 2006
- Country
- OPK United States
- OCUL United States
- Employees
- OPK N/A
- OCUL N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- OCUL Health Care
- Exchange
- OPK Nasdaq
- OCUL Nasdaq
- Market Cap
- OPK 1.0B
- OCUL 1.2B
- IPO Year
- OPK 1995
- OCUL 2014
- Fundamental
- Price
- OPK $1.68
- OCUL $7.00
- Analyst Decision
- OPK Strong Buy
- OCUL Strong Buy
- Analyst Count
- OPK 3
- OCUL 7
- Target Price
- OPK $2.75
- OCUL $16.71
- AVG Volume (30 Days)
- OPK 2.8M
- OCUL 940.9K
- Earning Date
- OPK 02-27-2025
- OCUL 03-10-2025
- Dividend Yield
- OPK N/A
- OCUL N/A
- EPS Growth
- OPK N/A
- OCUL N/A
- EPS
- OPK N/A
- OCUL N/A
- Revenue
- OPK $711,408,000.00
- OCUL $61,442,000.00
- Revenue This Year
- OPK N/A
- OCUL $11.40
- Revenue Next Year
- OPK $0.00
- OCUL $13.58
- P/E Ratio
- OPK N/A
- OCUL N/A
- Revenue Growth
- OPK N/A
- OCUL 6.45
- 52 Week Low
- OPK $0.86
- OCUL $4.06
- 52 Week High
- OPK $1.76
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- OPK 62.47
- OCUL 31.92
- Support Level
- OPK $1.60
- OCUL $7.14
- Resistance Level
- OPK $1.68
- OCUL $7.42
- Average True Range (ATR)
- OPK 0.06
- OCUL 0.37
- MACD
- OPK 0.01
- OCUL -0.02
- Stochastic Oscillator
- OPK 77.78
- OCUL 0.76
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.